6 photos

• Sort by: number of views (most to least) number of views (least to most) number of comments (most to least) number of comments (least to most) number of favorites (most to least) number of favorites (least to most) date uploaded (newest first) date uploaded (oldest first) random

• COVID-19 Vaccination Site

  • Uploaded by: U.S. Government Accountability Office
  • License: United States Government Work
  • 0 comments
  • 0 favorites
  • 4,317 views
  • Date uploaded: 2021-04-20
  • Tags: gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, gao21443, covid19, acip, advisorycommitteeonimmunizationpractices, cdc, centersfordiseasecontrolandprevention, coronavirusdisease2019, dod, departmentofdefense, eua, emergencyuseauthorization, fda, foodanddrugadministration, fema, federalemergencymanagementagency, hhs, departmentofhealthandhumanservices, nationalstrategy, nationalstrategyforthecovid19responseandpandemicpreparedness
  • Visibility: public
• Figure 2: Potential Choke Points in Scaling Up Vaccine Production Related to Key Manufacturing Challenges

  • Uploaded by: U.S. Government Accountability Office
  • License: United States Government Work
  • 0 comments
  • 0 favorites
  • 4,146 views
  • Date uploaded: 2021-04-20
  • Tags: gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, gao21443, covid19, acip, advisorycommitteeonimmunizationpractices, cdc, centersfordiseasecontrolandprevention, coronavirusdisease2019, dod, departmentofdefense, eua, emergencyuseauthorization, fda, foodanddrugadministration, fema, federalemergencymanagementagency, hhs, departmentofhealthandhumanservices, nationalstrategy, nationalstrategyforthecovid19responseandpandemicpreparedness
  • Visibility: public
• Figure 1. The vaccine development process typically takes 10 to 15 years under a traditional timeline. Multiple regulatory pathways, such as Emergency Use Authorization, can be used to facilitate bringing a vaccine for COVID-19 to market sooner.

  • Uploaded by: U.S. Government Accountability Office
  • License: United States Government Work
  • 0 comments
  • 0 favorites
  • 3,970 views
  • Date uploaded: 2020-05-29
  • Tags: gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, gao20583sp, covid19vaccinedevelopment, nationalinstituteofallergyandinfectiousdiseases, niaid, fda, foodanddrugadministration, eua, emergencyuseauthorizations
  • Visibility: public
• Figure 2. Vaccine candidates use different mechanisms, such as those shown above, to prompt the body to produce antibodies against SARS-CoV-2.

  • Uploaded by: U.S. Government Accountability Office
  • License: United States Government Work
  • 0 comments
  • 0 favorites
  • 3,864 views
  • Date uploaded: 2020-05-29
  • Tags: gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, gao20583sp, covid19vaccinedevelopment, nationalinstituteofallergyandinfectiousdiseases, niaid, fda, foodanddrugadministration, eua, emergencyuseauthorizations
  • Visibility: public
• Figure 4: Overview of the Four Vaccine Platform Technologies Considered by Operation Warp Speed, as of January 2021

  • Uploaded by: U.S. Government Accountability Office
  • License: United States Government Work
  • 0 comments
  • 0 favorites
  • 2,745 views
  • Date uploaded: 2021-02-11
  • Tags: gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, gao21319, operationwarpspeed, acip, advisorycommitteeonimmunizationpractices, barda, biomedicaladvancedresearchanddevelopmentauthority, bla, biologicslicenseapplication, cdc, centersfordiseasecontrolandprevention, cgmp, currentgoodmanufacturingpractice, covid19, coronavirusdisease2019, dod, departmentofdefense, eua, emergencyuseauthorization, fda, foodanddrugadministration, glp, goodlaboratorypractice, hhs, departmentofhealthandhumanservices, ind, investigationalnewdrug, mrna, messengerrna, ows, rd, researchanddevelopment, trl, technologyreadinesslevel, vrbpac, vaccinesandrelatedbiologicalproductsadvisorycommittee
  • Visibility: public
• Cumulative Number of COVID-19 Tests and Sample Collection Devices Authorized by FDA for Emergency Use, 2020-2021

  • Uploaded by: U.S. Government Accountability Office
  • License: United States Government Work
  • 0 comments
  • 0 favorites
  • 1,482 views
  • Date uploaded: 2022-05-20
  • Tags: gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, covid19, gao22104266, caresact, coronavirusaidreliefandeconomicsecurityact, cdc, centersfordiseasecontrolandprevention, clia, clinicallaboratoryimprovementamendmentsof1988, eua, emergencyuseauthorization, fda, foodanddrugadministration, hhs, departmentofhealthandhumanservices, ldt, laboratorydevelopedtest, radx, rapidaccelerationofdiagnostics
  • Visibility: public